The Rise of Oral Proteins and Peptides

Published: November 2013

A new report published by Roots Analysis provides a comprehensive view of the emerging market of “Oral Proteins and Peptides”. Apart from profiling the various drugs which are in different stages of clinical trials, the study also talks about many upcoming technologies and how these could revolutionise the oral form of drug administration.

The lead analyst on the study confirms, “Protein and peptide therapeutics market is a multi-billion dollar market and researchers are trying their best to improve the therapy by devising strategies for their oral delivery.” The report portrays the efforts of many pharmaceutical companies in making the transition towards oral delivery by developing innovative technologies and testing multiple drug candidates based on these technologies.

“Various new technologies, addressing the challenges posed by oral delivery of peptides, have emerged in the recent past. Some of the prominent names include Axcess, GIPET, Peptelligence and Eligen. The continued innovation of these platforms will be critical to tap the future market potential and will govern how the market shapes up in the near future”

Amongst others, the report provides detailed profiles on the following molecules (including independent opinion on the likely sales forecast over the next ten years):

  1. Linzess
  2. IN-105
  3. Ostora
  4. Octreolin
  5. Plecanatide

Special case studies have also been included on the following molecules:

  1. Liprotamase
  2. Sandimmune
  3. DDAVP

The 144 page report highlights the work being done by many firms in this area. The growing collaboration between big and small pharma is helping the cause. The study predicts a rapid rise in the adoption of oral delivery of these molecules which will steadily take the market away from other modes of drug administration. Many molecules which are currently in pre-clinical / discovery phase are likely to drive the market in the long term.

Key topics covered in the report are:

  • Overview and background
  • Analysis of the drug pipeline
  • Detailed drug profiles
  • Market forecasts over the next ten years
  • Technological developments and partnerships
  • Comprehensive SWOT analysis

For sample pages, to request Executive Summary or to order full report, please send an email  to


About Roots Analysis

Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry